Adaptive Clinical Trials: Exploiting Sequential Patient Recruitment and Allocation
Randomized Controlled Trials (RCTs) are the gold standard for comparing the effectiveness of a new treatment to the current one (the control). Most RCTs allocate the patients to the treatment group and the control group by uniform randomization. We show that this procedure can be highly sub-optimal (in terms of learning) if -- as is often the case -- patients can be recruited in cohorts (rather than all at once), the effects on each cohort can be observed before recruiting the next cohort, and the effects are heterogeneous across identifiable subgroups of patients. We formulate the patient allocation problem as a finite stage Markov Decision Process in which the objective is to minimize a given weighted combination of type-I and type-II errors. Because finding the exact solution to this Markov Decision Process is computationally intractable, we propose an algorithm -- \textit{Knowledge Gradient for Randomized Controlled Trials} (RCT-KG) -- that yields an approximate solution. We illustrate our algorithm on a synthetic dataset with Bernoulli outcomes and compare it with uniform randomization. For a given size of trial our method achieves significant reduction in error, and to achieve a prescribed level of confidence (in identifying whether the treatment is superior to the control), our method requires many fewer patients. Our approach uses what has been learned from the effects on previous cohorts to recruit patients to subgroups and allocate patients (to treatment/control) within subgroups in a way that promotes more efficient learning.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
TrialSynth: Generation of Synthetic Sequential Clinical Trial Data
Analyzing data from past clinical trials is part of the ongoing effort to optimize the design, implementation, and execution of new clinical trials and more efficiently bring life-saving interventions to market. While th…
TREEMENT: Interpretable Patient-Trial Matching via Personalized Dynamic Tree-Based Memory Network
Clinical trials are critical for drug development but often suffer from expensive and inefficient patient recruitment. In recent years, machine learning models have been proposed for speeding up patient recruitment via a…
Efficient adaptive designs for clinical trials of interventions for COVID-19
The COVID-19 pandemic has led to an unprecedented response in terms of clinical research activity. An important part of this research has been focused on randomized controlled clinical trials to evaluate potential therap…
Am I eligible? Natural Language Inference for Clinical Trial Patient Recruitment: the Patient's Point of View
Recruiting patients to participate in clinical trials can be challenging and time-consuming. Usually, participation in a clinical trial is initiated by a healthcare professional and proposed to the patient. Promoting cli…
Natural Language InferenceMatchMiner-AI: An Open-Source Solution for Cancer Clinical Trial Matching
Clinical trials drive improvements in cancer treatments and outcomes. However, most adults with cancer do not participate in trials, and trials often fail to enroll enough patients to answer their scientific questions. A…